Managing chronic shoulder pain with a new treatment approach
Addition of Pulsed Radiofrequency to Suprascapular Nerve Block With Glenohumeral Steroid Injection in Patients With Chronic Shoulder Pain
This study is testing a new treatment that combines special nerve injections and ultrasound-guided steroid shots to see if it can help people with chronic shoulder pain who haven't found relief with regular treatments.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 21 Years to 60 Years |
| Sex | All |
| Sponsor | Ain Shams University Academic / other |
| Locations | 1 site (Cairo) |
| Trial ID | NCT06106490 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of combining pulsed radiofrequency (PRF) treatment with suprascapular nerve injections and ultrasound-guided steroid injections in patients suffering from chronic shoulder pain. The focus is on assessing changes in pain levels and functional outcomes for individuals who have not responded adequately to conventional treatments. By utilizing advanced pain management techniques, the study aims to provide a more effective solution for chronic shoulder pain management.
Who should consider this trial
Good fit: Ideal candidates are adults aged 21-60 with chronic shoulder pain lasting more than three months and inadequate response to conservative treatments.
Not a fit: Patients with a history of shoulder surgery, certain chronic pain syndromes, or uncontrolled diabetes may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve pain relief and functional outcomes for patients with chronic shoulder pain.
How similar studies have performed: While the combination of PRF and nerve blocks is gaining popularity, this specific approach has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged from 21-60 years. * Patients with American Society of Anesthesiologists (ASA) physical status I and II. * Chronic shoulder pain (\>3 months) and will undergo interventional treatment due to inadequate response to conservative treatments. Exclusion Criteria: * Refusal of procedure or participation in the study by patients. * History of shoulder surgery, another intervention history between 3 months before and 1 year after the intervention applied. * Patients with chronic pain syndrome due to other shoulder pathology (fibromyalgia, cervical discopathy, brachial plexus injury). * Uncontrolled diabetes mellitus patients with glycated hemoglobin (HbA1C) levels of more than 7%. * Patients with known history of allergy to the study drugs. * Infection at site of injection. * Cognitive or psychiatric illness that will lead to inability to cooperate, speak, or provide informed consent.
Where this trial is running
Cairo
- Faculty of medicine Ain Shams University — Cairo, Egypt (Recruiting)
Study contacts
- Study coordinator: Nahla yahia, Msc
- Email: nahla.yahya@med.asu.edu.eg
- Phone: 00201000312825
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.